Figure 2

Changes in PHA-induced IL2 mRNA before and after bortezomib treatment. The fold changes in PHA-induced IL2 mRNA expression at Day 0 (D0), Days 2–3 (D2–3) and Weeks 1–3 (W1–3) were compared among the patients with BiPN grade 0 (a), grade 1 (b) and grade 2–3 (c). P-values were calculated using both parametric (paired Student’s t-test) (t) and non-parametric (paired Wilcoxon (W)) tests.